发明名称 |
A medicament for the treatment of a fibrotic disorder, and anti-fibrotic composition. |
摘要 |
<p>Human interferon is utilised in the manufacture of a medicament for the treatment of a fibrotic disorder. The medicament is administered to raise the total concentration of human interferons in the affected tissue area to about 10 to about 4 x 10<7> IU of interferon per cubic centimeter. The human interferon used can be naturally derived or recombinant DNA-derived alpha, beta or gamma-interferon. The interferon can be adminstered by any indicated conventional method and in any suitable, pharmaceutically acceptable, compatible vehicle.</p> |
申请公布号 |
EP0328255(A1) |
申请公布日期 |
1989.08.16 |
申请号 |
EP19890300476 |
申请日期 |
1989.01.19 |
申请人 |
BAKER CUMMINS PHARMACEUTICALS, INC. (A FLORIDA CORPORATION) |
发明人 |
BERMAN, BRIAN;DUNCAN, MATTHEW R. |
分类号 |
A61K38/21;A61K38/00;A61P1/16;A61P13/02;A61P15/00;A61P43/00;A61P17/00 |
主分类号 |
A61K38/21 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|